Category Archives: Foreign M&A / 外资并购

Strategic Investment in Chinese Listed Companies by Foreign Investors (2024 Rules in Force for 2026)

  • The revised Measures (six agencies, Order No. 3, 2024; published 1 Nov 2024, effective 2 Dec 2024) are the governing rule for foreign strategic investment in A-share listed companies.
    修订后的《办法》(六部门,第3号令,2024;2024年11月1日公布,2024年12月2日施行)是外国投资者对A股上市公司战略投资的主管规则。
  • Qualifying methods are three: directed new issue, agreement transfer, and tender offer — all requiring medium-to-long-term holding of A-shares.
    合格方式三种:上市公司定向发行新股、协议转让、要约收购——均须中长期持有A股。
  • The 2024 revision allows foreign natural persons, eases asset thresholds (USD 50m owned / USD 3bn managed for non-controlling; USD 100m / USD 500m for controlling), and permits overseas unlisted-company equity in directed issues and tender offers (cross-border share swap).
    2024修订允许外国自然人、放宽资产门槛(非控股实有5000万美元/管理3亿美元;控股1亿/5亿美元),并允许定向发行与要约收购中使用境外非上市公司股权(跨境换股)。
  • The holding-ratio requirement for agreement transfer / tender offer is cut from 10% to 5% (and eliminated for directed issues); the lock-up is cut from three years to twelve months (or longer if other rules require).
    协议转让/要约收购的持股比例要求由10%降至5%(定向发行取消比例);锁定期由3年降至12个月(其他规则有更长要求从其规定)。
  • No commerce-department approval is needed; the deal runs through information reporting and securities-market rules, with interfaces to security review and merger control preserved.
    无需商务部门审批;交易经信息报告与证券市场规则办理,安全审查与经营者集中接口保留。
  • Restrictions bind: no investment in negative-list prohibited sectors; restricted sectors must meet the list’s equity/management conditions; and security review applies where national security is or may be affected.
    限制有效:不得投资负面清单禁止领域;限制领域须满足清单股权/管理条件;影响或可能影响国家安全的须通过安全审查。

Strategic Investment in Chinese Listed Companies by Foreign Investors (2024 Rules in Force for 2026) | 外国投资者对上市公司战略投资(2024规则2026年适用)

The rule that governs listed-company stake-building

For a foreign investor taking a strategic stake in a Chinese A-share listed company, the governing instrument is the revised *Measures for the Administration of Strategic Investment in Listed Companies by Foreign Investors*. Adopted at the 13th ministerial executive meeting of MOFCOM on 15 August 2024, agreed by CSRC, SASAC, the State Taxation Administration, SAMR and SAFE, it was promulgated as six-agency Order No. 3 of 2024 on 1 November 2024 and took effect on 2 December 2024, repealing the 2005 version. In 2026 it is the live framework, and every foreign strategic investment in a listed company routes through it.

“Strategic investment” here means a foreign investor acquiring and medium-to-long-term holding A-shares through a listed company’s directed new issue (定向发行), agreement transfer (协议转让) or tender offer (要约收购), or other legally permitted means. The statutory principles are clear: comply with law, no harm to national security or public interest, open/fair/just treatment, medium-to-long-term investment (no speculation), and no exclusion or restriction of competition.

Who qualifies, and how

A foreign investor is a foreign natural person, enterprise or other organisation. To qualify, the investor must be lawfully established and operating, financially sound, creditworthy, with mature management experience, sound governance and internal controls; a foreign natural person must have corresponding risk-identification and risk-bearing capacity. Asset thresholds were eased in 2024: a non-controlling investor needs owned tangible assets of no less than USD 50 million or managed tangible assets of no less than USD 3 billion; a controlling investor needs USD 100 million owned or USD 500 million managed. The investor must not have suffered criminal punishment or a major regulatory penalty at home or abroad in the prior three years.

Crucially, the 2024 revision allows foreign natural persons to make strategic investment (previously excluded). It also permits cross-border share swaps: where the investor uses equity in an overseas company, or its own newly issued shares, as consideration, the overseas company must be lawfully established in a jurisdiction with a sound company-law system and its management must not have had a major regulatory penalty in three years; for agreement-transfer structures, that overseas company must itself be listed.

Three methods and the relaxed thresholds

The three permitted methods each carry a tailored path:

  • Directed new issue — the foreign investor subscribes new A-shares as a pre-determined or competitively determined issuer. The 2024 revision eliminates the prior 10% minimum holding requirement for this method.
  • Agreement transfer — the acquired stake must be no less than 5% of issued shares (cut from 10%).
  • Tender offer — the预定的 acquired stake must be no less than 5% (cut from 10%).

The lock-up was cut from no less than three years to no less than twelve months (longer if the Securities Law, the Acquisition Management Measures or the Securities Issuance Registration Measures require). Shares acquired via strategic investment may not be transferred within 12 months; transfers before expiry are permitted only for death, legal-person termination or court enforcement, subject to securities rules.

These changes directly lower the cost and raise the flexibility of a foreign strategic position — a 5% agreement-transfer stake with a one-year lock is a fundamentally different proposition from the old 10%/three-year regime.

Information reporting, not approval

Post-Foreign-Investment-Law, strategic investment no longer requires commerce-department approval. The investor and the listed company file foreign-investment information after completion (and after each shareholding change exceeding 5% or a change in foreign control/relative-control status). Securities-market disclosure and other obligations under the Securities Law and CSRC/ exchange rules apply.

Intermediaries (financial advisers, sponsors or law firms registered in China) must conduct due diligence and issue opinions on compliance — notably whether the investment affects national security, touches the negative list, and meets the qualification conditions. If the opinion finds non-compliance, the securities registration and clearing institution will not process the relevant procedures. This makes intermediary selection and a clean due-diligence file decisive to a successful closing.

Negative list and security interfaces

Two hard limits bind. First, the negative list: a foreign investor may not strategically invest in a listed company in a sector the negative list prohibits; where the list restricts a sector, the investment must satisfy the list’s equity and senior-management conditions. Second, security review: if the investment affects or may affect national security, the *Foreign Investment Security Review Measures* apply (see the dedicated article in this series). Third, merger control: if the strategic investment constitutes a concentration reaching the State Council thresholds, SAMR notification is required before implementation.

The 2024 revision also clarifies carve-outs: QFII/RQFII investments, Stock Connect (沪深港通) investments, shares obtained when a foreign-invested joint-stock company lists on A-shares, and certain foreign-natural-person secondary-market or incentive purchases are outside the Measures but remain subject to other rules. A foreign investor’s aggregate holdings through multiple channels (including QFII/RQFII and Connect) must still respect the sector limits and control caps.

What to do next

  • Confirm the target’s sector against the negative list before structuring — prohibited sectors are out, restricted sectors need list-compliant conditions.
  • Choose the method by intent: directed issue (no min ratio, flexible), agreement transfer or tender offer (≥5%, one-year lock).
  • Prepare the asset-evidence package (USD 50m/USD 3bn, or USD 100m/USD 500m if controlling) and the three-year clean-record proof.
  • Engage a China-registered intermediary early for the compliance opinion; non-compliant opinions block registration.
  • Route the filing through information reporting, not commerce approval, and respect disclosure duties.
  • Screen security review and merger control in parallel; they can override an otherwise clean strategic investment.

Post-investment obligations and the reporting cadence

After closing, the obligations continue. The investor and the listed company must file foreign-investment information upon completion, and again each time the foreign shareholding changes by more than 5% or the foreign control / relative-control status changes. Securities-law disclosure duties (change-of-interest reports, tender-offer documents, voting-right disclosures) run in parallel. The 12-month lock-up bars transfer except for death, legal-person termination or court enforcement; breaches can draw warnings, fines or a prohibition on exercising voting or disposing shares until cured.

Aggregation with QFII and Connect holdings

A subtle trap is aggregation. The Measures carve out QFII/RQFII and Stock Connect investments, but the intermediary’s due-diligence opinion must state the investor’s and its concert parties’ total holdings across all channels — including those carve-outs — to confirm the sector limits and control caps are respected. A foreign investor that holds 4% via QFII and seeks a 5% strategic agreement-transfer stake therefore approaches, and must plan around, the relevant sector ceiling and any control test. Modelling the combined position before signing avoids a last-minute structure change.

A short worked example

A foreign investment fund (not a natural person) wishes a 5% strategic stake in an A-share manufacturer via agreement transfer, with no board control. It must evidence USD 50m owned or USD 3bn managed, a clean three-year record, and engage a China-registered intermediary for the compliance opinion. Post-closing, it files investment information and respects the 12-month lock-up. Because it holds no board seat and under 50%, “actual control” is unlikely — but if the manufacturer is in a negative-list restricted sector, the investment must still meet the list’s equity/senior-management conditions, and the 5% stake plus any QFII holding must be aggregated for the sector ceiling. The structure is lawful and light, exactly the 2024 revision’s intent.


外国投资者对上市公司战略投资(2024规则2026年适用)

管辖上市公司入股的规则

外国投资者对中国A股上市公司进行战略入股,主管文件为修订后的《外国投资者对上市公司战略投资管理办法》。该办法于2024年8月15日经商务部第13次部务会议审议通过,并经证监会、国资委、税务总局、市场监管总局、外汇局同意,2024年11月1日以六部门2024年第3号令公布,2024年12月2日施行,同时废止2005年版。2026年它是现行框架,一切外国投资者对上市公司的战略投资均经此办理。

此处”战略投资”指外国投资者通过上市公司定向发行新股、协议转让、要约收购或其他法定方式,取得并中长期持有A股股份。法定原则明确:遵守法律,不危害国家安全与社会公共利益,公开、公平、公正,中长期投资(不得炒作),不妨碍公平竞争、不排除限制竞争。

谁合格、如何投资

外国投资者指外国的自然人、企业或其他组织。合格须依法设立经营、财务稳健、资信良好、具成熟管理经验、治理与内控健全;外国自然人须具备相应风险识别与承担能力。资产门槛在2024年放宽:非控股股东实有资产总额不低于5000万美元或管理实有资产总额不低于3亿美元;控股股东实有资产总额不低于1亿美元或管理不低于5亿美元。近3年未受境内外刑事处罚或监管重大处罚。

关键的是,2024修订允许外国自然人战略投资(此前排除)。亦允许跨境换股:投资者以持有境外公司股权或以其增发股份作为支付手段的,境外公司须依法设立、注册地具完善公司法律制度、管理层近3年未受重大处罚;协议转让方式下该境外公司须为上市公司。

三种方式与放宽门槛

三种允许方式各有路径:

  • 定向发行——外国投资者作为董事会预先确定或竞价确定的发行对象认购新股。2024修订取消此方式原10%最低持股要求。
  • 协议转让——取得股份比例不得低于已发行股份5%(由10%降至5%)。
  • 要约收购——预定收购比例不得低于已发行股份5%(由10%降至5%)。

锁定期由不低于3年降至不低于12个月(若《证券法》《收购管理办法》《证券发行注册管理办法》有更长要求从其规定)。战略投资取得A股12个月内不得转让;期满前仅因死亡、法人终止或司法扣划等方可转让,并须遵守证券规则。

这些变化直接降低了外国战略持仓的成本、提升了灵活性——5%协议转让加一年锁定期,与旧制10%/3年全然不同。

信息报告而非审批

《外商投资法》后,战略投资不再需商务审批。投资者与上市公司在完成后(及每次持股变动超5%或外资控股/相对控股地位变化后)报送外商投资信息。证券法及证监会、交易所规则下的信息披露等义务适用。

中介机构(中国注册的财务顾问、保荐机构或律所)须尽职调查并就合规性出具意见——尤其是否影响国家安全、是否触及负面清单、是否符合资格条件。若意见认定不合规,证券登记结算机构不予办理相关手续。这使得中介机构选择与干净的尽调档案成为成功交割的关键。

负面清单与安全审查接口

两道硬约束。其一,负面清单:外国投资者不得对负面清单禁止领域上市公司战略投资;限制领域须满足清单股权与高管条件。其二,安全审查:影响或可能影响国家安全的,适用《外商投资安全审查办法》(见本系列专文)。其三,经营者集中:若战略投资构成达国务院门槛的集中,须在实施前通知SAMR。

2024修订亦明确排除情形:QFII/RQFII投资、沪深港通投资、外商投资股份公司A股上市取得股份、以及符合证监会规定的外国自然人二级市场或股权激励取得,不在本办法范围但仍受其他规则约束。外国投资者经多通道(含QFII/RQFII与互联互通)的合计持股仍须遵守行业限制与控制上限。

下一步

  • 架构设计前将目标行业对照负面清单——禁止领域排除,限制领域须满足清单条件。
  • 按意图选方式:定向发行(无最低比例、灵活)、协议转让或要约收购(≥5%、一年锁定期)。
  • 准备资产证明包(5000万/3亿,或控股1亿/5亿)及三年无处罚记录。
  • 尽早聘请中国注册中介机构出具合规意见;不合规意见将阻断登记。
  • 经信息报告而非商务审批路径申报,并遵守披露义务。
  • 并行筛查安全审查与经营者集中,二者可推翻原本干净的战略投资。

投资后义务与申报节奏

交割后义务仍在继续。投资者与上市公司须于完成后报送外商投资信息,并在外国持股变动超5%或外资控股/相对控股地位变化后再次报送。证券法下的披露义务(权益变动报告、要约收购文件、表决权披露)并行适用。12个月锁定期禁止转让,仅死亡、法人终止或司法扣划除外;违约可招致警告、罚款或暂停表决权与处分权直至纠正。

与QFII及互联互通持股的合并计算

一个隐蔽陷阱是合并计算。《办法》排除QFII/RQFII与沪深港通投资,但中介尽调意见须列示投资者及其一致行动人经所有通道(含上述排除)的合计持股,以确认遵守行业限制与控制上限。故通过QFII持有4%、又拟以协议转让战略持股5%的外国投资者,已逼近且须筹划相关行业上限与控制测试。签约前建模合并持仓,可避免临门更改结构。

简例演示

某外国投资基金(非自然人)拟以协议转让取得某A股制造商5%战略股,不谋董事会控制。它须证明实有5000万美元或管理3亿美元、三年无处罚记录,并聘请中国注册中介出具合规意见。交割后报送投资信息、遵守12个月锁定期。因其无董事席位且低于50%,”实际控制”大概率不触发——但若制造商处负面清单限制领域,投资仍须满足清单股权/高管条件,且5%持股与任何QFII持仓须合并计算行业上限。该结构合法且轻量,正是2024修订的用意。

Sources

Merger-Control Filing in 2026: Thresholds, Simplified Track and Delegated Review

  • The notifiable thresholds (Order No. 773, effective 26 Jan 2024) are: worldwide turnover >RMB 12bn with two parties each >RMB 800m in China, OR China aggregate >RMB 4bn with two parties each >RMB 800m in China; sub-threshold deals with competition concerns can still be called in.
    申报门槛(第773号令,2024年1月26日施行):全球合计超120亿元且两方中国各超8亿元,或中国合计超40亿元且两方中国各超8亿元;未达门槛但有竞争关切的交易仍可被要求申报。
  • In 2025 SAMR concluded 706 concentrations (+9.8%); in May 2025–April 2026 it cleared 232 involving private firms with total value RMB 353.4bn, averaging 26.72 days to conclude (15.64 days acceptance / 18.9 days conclusion for simplified cases).
    2025年SAMR审结706件(+9.8%);2025年5月至2026年4月审结涉民营企业232起、总额3534亿元,平均审结26.72天(简易案件受理15.64天/审结18.9天)。
  • Delegated review became formal in August 2025 and was refined in March 2026; provincial bureaus have cleared deals in as little as 11 days (e.g., Qingyuan Desheng & Shengli Steel).
    委托审查于2025年8月转为正式、2026年3月完善;省级局最快11天审结(如清远德晟与圣力钢制品案)。
  • SAMR issued the Concentration Filing Norms and Non-Horizontal Review Guidelines, plus a penalty-discretion baseline, giving parties a transparent, predictable filing environment.
    SAMR出台《经营者集中申报规范》《非横向经营者集中审查指引》及处罚裁量基准,为企业提供透明可预期的申报环境。
  • A June 2026 special enforcement campaign (June–December) will explore “green channels” for specific industries and strengthen compliance reminders and local guidance windows.
    2026年6月启动的专项行动(6–12月)将探索特定行业审查”绿色通道”,并强化申报提醒与地方指导窗口。
  • Gun-jumping is policed: in 2025 SAMR publicly investigated 4 illegal-concentration cases with RMB 6.95m in fines, and below-threshold deals with competition risk can be called in.
    “抢跑”受监管:2025年SAMR公开查处4起违法实施经营者集中案件、罚款695万元,且有竞争风险的未达门槛交易可被要求申报。

Merger-Control Filing in 2026: Thresholds, Simplified Track and Delegated Review | 2026年经营者集中申报:门槛、简易案件与委托审查

When a filing is required

Under the *Provisions on the Notification Thresholds for Concentration of Undertakings* (State Council Order No. 773, effective 26 January 2024), a concentration must be notified to SAMR before implementation where, in the prior fiscal year, the worldwide aggregate turnover of all parties exceeds RMB 12 billion and at least two parties each had China turnover above RMB 800 million; OR the parties’ aggregate China turnover exceeds RMB 4 billion and at least two parties each had China turnover above RMB 800 million. Banking, insurance, securities and futures use sector-specific calculation rules. A concentration is notifiable even where it does not meet these thresholds if there is evidence it may eliminate or restrict competition — SAMR may require a filing.

The 2024 revision raised the earlier levels (RMB 10bn / RMB 2bn / RMB 400m) to RMB 12bn / RMB 4bn / RMB 800m, which SAMR estimated would cut notifiable deals by about 30%, lowering transaction costs for smaller mergers while keeping scrutiny on competitively risky ones.

Throughput and the simplified track

SAMR’s 2025 performance was substantial: 706 concentrations lawfully concluded, up 9.8% year-on-year, with 83% closing at the 30-day preliminary-review stage. The agency applies “fast review without lowering quality” in automotive, photovoltaic and lithium-battery fields to support restructuring.

The simplified track targets a “double 20-day” standard (acceptance and review). In the May 2025–April 2026 window, SAMR concluded 232 concentrations involving private firms, with total transaction value of RMB 353.4 billion; average acceptance time was 17.13 days and average conclusion time 26.72 days. For simplified cases, average acceptance was just 15.64 days and average conclusion 18.9 days — better than the internal “double 20” requirement. For a foreign acquirer, this means a clean, below-concern deal can clear in roughly three to four weeks.

Delegated review: closer to the market

A notable 2025–2026 reform is delegated review. In August 2025, SAMR moved the pilot delegated review with selected provincial market-regulation bureaus to formal delegated review; in March 2026 it issued an announcement further refining the system. Delegated bureaus use their proximity to bring faster, more localised service. Examples: the Chongqing bureau concluded the Zhejiang Jirun Automobile / Maichi Zhixing joint-venture case in 18 days from filing to clearance; the Guangdong bureau handled the Qingyuan Desheng Investment / Shengli Steel new joint-venture case in just 11 days of review. For foreign investors with deals centred in a delegated province, this can materially shorten the clock.

Transparency and compliance tooling

To make filing predictable, SAMR has issued the *Concentration Filing Norms* and the *Non-Horizontal Concentration Review Guidelines*, opened the operator-concentration antitrust business system with a 6,000-plus-case historical library for real-time query, and released a penalty-discretion baseline (trial) with a self-calculation tool so parties “see and understand at a glance”. It also warned of and acted on “gun-jumping”: in 2025 it publicly investigated 4 illegal-concentration cases with RMB 6.95 million in fines, and in key fields (semiconductors, shipping, minerals) conditionally approved 5 and prohibited 1 to protect supply-chain competition.

The June 2026 efficacy campaign

On 30 June 2026, SAMR launched a special enforcement campaign (June–December) to raise operator-concentration antitrust regulatory efficacy. Its three pillars matter to deal-makers:

  1. Regulatory capacity — explore “green channels” for specific industries, strengthen complex-issue research, and support delegated provincial bureaus with expert backing.
  2. Full-chain efficacy — maintain the simplified “double 20-day” standard, optimise the business system, publish typical cases, and handle major-merger reviews with close listening to relevant parties.
  3. Compliance guidance — improve filing reminders, issue policy guidance, run targeted training for firms above the threshold, and support local “filing guidance windows”.

For foreign acquirers, the practical signals are: faster, more transparent review; a realistic prospect of industry-specific fast lanes; and a clear expectation that below-threshold but competition-risky deals will still be scrutinised.

What to do next

  • Run the threshold test early; if close to the line, assume a filing and budget the timeline.
  • Prefer the simplified track where the deal is clean (no overlap or minor overlap); target the ~3–4 week clearance.
  • Check whether your province runs delegated review; if so, file there to use local proximity.
  • Use SAMR’s case library and filing norms to pre-assess overlap and prepare a tight submission.
  • Do not close before clearance — gun-jumping draws public penalties even for foreign parties.
  • Watch for industry “green channels” announced in the 2026 campaign when planning sensitive-sector deals.

What to submit and how long it really takes

A filing package centres on the notification form, the parties’ audited turnover, the transaction documents (SPA, shareholder agreements), and a competitive-effects analysis where overlap exists. SAMR’s published norms and the 6,000-plus case library let counsel benchmark whether a deal is “simple” (little or no horizontal overlap, no vertical foreclosure) and thus eligible for the simplified track. For a clean deal, the realistic clock is acceptance (~15 days) plus review (~20 days) — about a month — though parties should still build buffer for information requests.

Sector sensitivity: semiconductors, minerals, pharma

2025–2026 enforcement shows where scrutiny concentrates. SAMR prohibited one deal and conditionally approved five in semiconductors, shipping and minerals, protecting supply-chain competition. In the May 2025–April 2026 window, notable conditional approvals included the Synopsys–Ansys (新思科技收购安似科技) and Bunge–Viterra (邦吉收购蔚特) cases, and the Chilean copper / Chilean chemical joint venture (lithium carbonate supply) — conditioned to secure stable, reasonably priced supply for downstream Chinese firms, including private new-energy buyers. The lesson: deals touching critical inputs or semiconductor capacity should expect a substantive review even if turnover is modest.

Avoiding gun-jumping penalties

“Gun-jumping” — closing or integrating before clearance — is actively policed, with RMB 6.95m in fines across four cases in 2025 and public naming. Foreign parties are not exempt. The safe pattern is to sign subject to a condition precedent (merger-control clearance), keep the businesses separate until approval, and resist operational integration (shared pricing, combined sales forces, unified procurement) during the pending period. Where a deal is below the thresholds but competitively sensitive, assume SAMR may call it in and pre-empt by consulting the agency.

Filing readiness: a pre-filing checklist

To avoid avoidable delay, assemble the package before signing. Confirm the correct turnover figures from audited statements for the relevant fiscal year; map the overlap matrix (horizontal shares, vertical relationships) across the parties’ product markets; prepare the transaction documents and any remedy proposals; and decide whether to request the simplified track. Where a party is foreign, localise the turnover evidence and appoint a China-registered agent if needed. Engagement with SAMR or the delegated provincial bureau ahead of formal filing — using the published norms and case library — often surfaces a fatal overlap early, when it is still cheap to restructure rather than after a prohibition.

Looking ahead from the 2026 campaign

The June–December 2026 efficacy campaign signals a steady-state direction: faster, more transparent, and more sector-aware review. The exploration of industry “green channels” means that, later in 2026, certain strategic sectors may get a dedicated fast lane, while the emphasis on filing reminders and local guidance windows lowers the cost of getting it right the first time. For foreign acquirers, the trend is favourable — provided the deal is genuinely clean and the submission is well-prepared. The agency’s message is consistent: support lawful consolidation, police the rest.


2026年经营者集中申报:门槛、简易案件与委托审查

何时需要申报

依《国务院关于经营者集中申报标准的规定》(国务院第773号令,2024年1月26日施行),上一会计年度所有当事人全球合计营业额超120亿元且至少两方中国境内各超8亿元,或当事人中国境内合计营业额超40亿元且至少两方中国境内各超8亿元,须在实施前通知SAMR。银行、保险、证券、期货按行业特别规则计算。即使未达上述门槛,若有证据证明可能排除、限制竞争,SAMR亦可要求申报。

2024年修订将原有标准(100亿/20亿/4亿)提高至120亿/40亿/8亿元,SAMR估计可使申报量减少约30%,在降低中小并购交易成本的同时,保留对具竞争风险交易的审查。

审结量与简易案件

SAMR 2025年表现突出:依法审结经营者集中706件,同比增长9.8%,83%在30天初步审查阶段结案。该局在汽车、光伏、锂电池领域”快审不降质”以支持重组。

简易案件目标为”双20天”(受理与审查)。2025年5月至2026年4月,SAMR审结涉民营企业经营者集中232起,交易总额3534亿元;平均受理17.13天、平均审结26.72天。简易案件平均受理仅15.64天、审结18.9天,优于内部”双20″要求。对外国收购方而言,这意味着干净、无竞争关切的交易约三至四周即可通过。

委托审查:更贴近市场

2025–2026年一项显著改革是委托审查。2025年8月,SAMR将试点委托审查转为正式委托;2026年3月发布公告进一步完善制度。受委托省级局发挥贴近优势,提供更快速、本地化服务。例证:重庆市局审结浙江吉润汽车与迈驰智行新设合营企业案,自申报到审结仅18天;广东省局审查清远德晟投资与圣力钢制品新设合营企业案,审查阶段仅11天。对交易集中于受委托省份的外国投资者,此举可显著缩短周期。

透明度与合规工具

为提升申报可预期性,SAMR出台《经营者集中申报规范》《非横向经营者集中审查指引》,开放经营者集中反垄断业务系统(6000余件历史案例库实时查询),并发布处罚裁量基准(试行)及”行政处罚自算器”,使企业”一看就懂、一算便知”。该局亦警示并查处”抢跑”:2025年公开查处4起违法实施经营者集中案件、罚款695万元;在半导体、航运、矿产等关键领域附条件批准5件、禁止1件,以保障产业链竞争。

2026年6月效能专项行动

2026年6月30日,SAMR启动经营者集中反垄断监管效能提升专项行动(6–12月)。其三大支柱对交易方重要:

  1. 监管基础能力——探索特定行业审查”绿色通道”,加强复杂问题研究,以外部专家支撑受委托省级局。
  2. 全链条质效——认真执行简易案件”双20天”,优化业务系统,做好典型案例公开,充分听取相关方对重大并购审查意见。
  3. 合规指导——完善申报提醒,发布政策指引,对达申报标准企业开展专项培训,支持有条件地区建立申报指导窗口。

对外国收购方的实务信号是:审查更快更透明;特定行业快车道可期待;未达门槛但有竞争风险的交易仍将被审查。

下一步

  • 尽早做门槛测试;若接近临界,按需申报并排期。
  • 交易干净(无重叠或轻微重叠)时优先走简易案件,目标约3–4周通过。
  • 查核所在省份是否实行委托审查;若是,就地申报以利用就近优势。
  • 利用SAMR案例库与申报规范预先评估重叠并准备精炼材料。
  • 未获核准前不得交割——”抢跑”即便对外方也招致公开处罚。
  • 规划敏感行业交易时,关注2026专项行动中宣布的行业”绿色通道”。

应提交什么及真实耗时

申报材料以申报表、各方经审计营业额、交易文件(SPA、股东协议)及存在重叠时的竞争影响分析为核心。SAMR已发布的规范与6000余件案例库,使律师可基准判断交易是否”简单”(横向重叠小或无、无纵向封锁)从而适用简易案件。对干净交易,现实时钟为受理(约15天)加审查(约20天)——约一个月,但仍应为信息补充请求留出缓冲。

行业敏感性:半导体、矿产、医药

2025–2026年执法显示审查集中于何处。SAMR在半导体、航运、矿产领域禁止1件、附条件批准5件,以保障产业链竞争。2025年5月至2026年4月,显著附条件批准包括新思科技收购安似科技、邦吉收购蔚特,以及智利铜业与智利化工新设合营企业案(碳酸锂供应)——附条件以确保下游中国企业(含民营新能源买方)获得稳定、合理价格的供应。启示:触及关键投入或半导体产能的交易,即便营业额不大,也应预期实质审查。

避免”抢跑”处罚

“抢跑”——核准前交割或整合——被积极监管,2025年4起案件罚款695万元并公开点名。外国当事方不豁免。安全做法是签署以经营者集中核准为先决条件的协议,核准前保持业务分离,并在待审期抵制运营整合(共享定价、合并销售队伍、统一采购)。对未达门槛但有竞争敏感性的交易,应预期SAMR可能要求申报,并主动与当局沟通以防患未然。

申报准备:申报前清单

为避免无谓延误,应在签约前备齐材料。依经审计报表确认相关会计年度的正确营业额;绘制各方产品市场的重叠矩阵(横向份额、纵向关系);准备交易文件与可能的救济方案;并决定是否申请简易案件。当事人一方为外国的,应本土化营业额证据,必要时委任中国注册代理人。在正式申报前借助已发布规范与案例库与SAMR或受委托省级局沟通,往往能尽早暴露致命重叠——此时重构成本低,远胜禁止之后。

自2026专项行动看未来

2026年6–12月效能专项行动指向一个稳态方向:更快、更透明、更具行业意识。对特定行业”绿色通道”的探索意味着,2026年下半年某些战略行业或获专属快车道;而强调申报提醒与地方指导窗口,降低了”一次做对”的成本。对外国收购方,趋势有利——前提是交易确属干净、申报准备充分。该局信号一致:支持合法整合,监管其余。

Sources

Foreign M&A in China in 2026: Review Map and Timelines

  • Since the Foreign Investment Law (2020), acquiring a domestic firm is no longer a commerce-approval event; it runs through the negative list, information reporting, plus merger control and security review where triggered.
    自《外商投资法》(2020)以来,并购境内企业不再是商务审批事件——经负面清单、信息报告办理,并在触发时通过经营者集中与安全审查。
  • Merger-control thresholds (State Council Order No. 773, effective 26 Jan 2024): worldwide turnover >RMB 12bn with two parties each >RMB 800m in China, OR China aggregate >RMB 4bn with two parties each >RMB 800m in China.
    经营者集中门槛(国务院第773号令,2024年1月26日施行):全球合计超120亿元且两方中国各超8亿元,或中国合计超40亿元且两方中国各超8亿元。
  • SAMR cleared 706 concentrations in 2025 (up 9.8%); 83% closed at the 30-day preliminary stage, with a “double 20-day” simplified track for straightforward cases.
    市场监管总局2025年审结经营者集中706件(增长9.8%);83%在30天初步审查阶段结案,简易案件推行”双20天”审查目标。
  • Security review is mandatory where the target is in a covered sensitive sector and the foreign investor obtains actual control — and its control test is broader than merger control’s.
    当目标位于受涵盖敏感领域且外国投资者取得实际控制权时须通过安全审查——其控制标准宽于经营者集中标准。
  • The 2024 strategic-investment rules (six-agency Order No. 3, effective 2 Dec 2024) ease listed-company investment: foreign natural persons allowed, lower asset thresholds, tender offers added, lock-up cut to 12 months, no commerce approval.
    2024年战投规则(六部门第3号令,2024年12月2日施行)放宽上市公司投资:允许外国自然人、降低资产门槛、新增要约收购、锁定期降至12个月、无需商务审批。
  • Run merger control, security review and sector licensing in parallel; do not close until every mandatory clearance is in hand, and begin both reviews at term-sheet stage.
    将经营者集中、安全审查与行业许可并行推进;未获所有强制核准前不得交割,并在条款书阶段启动两项审查。

Foreign M&A in China in 2026: Review Map and Timelines | 2026年外资并购中国:审查地图与时间线

The post-2020 deal frame

Acquiring a Chinese company as a foreign investor now sits inside the Foreign Investment Law regime rather than the older approval-based M&A rules. The behavioural shift is decisive: the deal is no longer a commerce-department approval event by itself. Instead, the investor incorporates or transfers under company law, clears any negative-list condition, files foreign-investment information, and — where triggered — separately clears merger control (antitrust) with the State Administration for Market Regulation (SAMR) and national security review with the NDRC-led mechanism. Understanding which gates actually apply, and running them in parallel, is the core of a smooth closing.

Gate 1 — the negative list and information reporting

The 2024 national negative list for foreign investment contains 29 items and took effect on 1 November 2024. If the target’s sector is on the list, the acquisition must satisfy its conditions (equity caps, Chinese-control requirements, etc.); if off the list, the deal is treated on equal terms with domestic M&A. Cross-border share swaps are permitted but conditioned — generally the foreign equity used as consideration should be in a listed overseas company, though the 2024 strategic-investment rules relaxed this for certain directed-issue and tender-offer structures. Post-deal, the foreign investor files investment information rather than seeking approval.

Gate 2 — merger control (antitrust) filing

A foreign acquirer must notify SAMR before implementing a concentration that meets the thresholds. Under the revised State Council regulation (Order No. 773, effective 26 January 2024), a concentration must be notified where, in the prior fiscal year, the worldwide aggregate turnover of all parties exceeds RMB 12 billion and at least two parties each had China turnover above RMB 800 million; OR the parties’ aggregate China turnover exceeds RMB 4 billion and at least two parties each had China turnover above RMB 800 million. Banking, insurance, securities and futures are calculated with sector-specific rules.

The 2024 revision raised the prior levels (RMB 10bn / RMB 2bn / RMB 400m) to RMB 12bn / RMB 4bn / RMB 800m, which SAMR estimated would cut notifiable deals by about 30% and reduce transaction costs. A deal must not close before clearance; “gun-jumping” draws penalties. SAMR runs a simplified track with a “double 20-day” target (acceptance and review) for straightforward cases, and has moved pilot delegated review with provincial bureaus to formal delegated review (trial delegation转为正式委托 in August 2025, refined by an announcement in March 2026).

The throughput is real: in 2025 SAMR lawfully concluded 706 concentration cases, up 9.8% year-on-year, with 83% closing at the 30-day preliminary-review stage. In key fields such as automotive, photovoltaics and lithium batteries, the agency applies “fast review without lowering quality” to support restructuring.

Gate 3 — national security review

Where the acquisition is in a covered sensitive sector and the foreign investor acquires actual control, security review is required before implementation. The *Measures for Foreign Investment Security Review* (NDRC and MOFCOM, issued 19 December 2020, effective 18 January 2021) define the covered scope: national defence and surrounding areas; and important agriculture, energy and resources, major equipment manufacturing, important infrastructure, important transport services, important culture, important IT and internet products/services, important financial services, key technologies and other important areas — where the investor obtains actual control.

The “actual control” test is broader than merger control’s: it includes holding 50%+ equity; holding under 50% but with voting rights that materially influence board/shareholder resolutions; or other circumstances where the investor materially influences business decisions, personnel, finance or technology. Procedure runs preliminary (15 working days to decide whether to review) → general review (30 working days) → special review (60 working days, extendable); the decision is final and may prohibit, condition or clear the deal. Because it can override a cleared merger filing, security review is the gate an acquirer must screen first — and, as the 2026 Meta–Manus prohibition showed, it is actively enforced (see the dedicated article in this series).

Listed-company strategic investment (2024 update)

Where the target is a listed company, the foreign investor must also comply with the revised *Measures for the Administration of Strategic Investment in Listed Companies by Foreign Investors* (six agencies, Order No. 3, 2024; published 1 November 2024, effective 2 December 2024). The revision materially lowers the bar: foreign natural persons are allowed; asset thresholds are eased (non-controlling investors need only USD 50m owned or USD 3bn managed; controlling investors need USD 100m owned or USD 500m managed); cross-border share swaps are eased for directed issues and tender offers; the strategic-investment methods add tender offers; the holding-ratio requirement for agreement-transfer/tender-offer is cut from 10% to 5% (and eliminated for directed issues); and the lock-up is cut from three years to twelve months (or longer if other rules require). Importantly, strategic investment no longer requires commerce-department approval — it is handled through information reporting and securities-market rules, with security-review and merger-control interfaces preserved.

A realistic timeline

A straightforward, unrestricted, below-threshold acquisition can complete in roughly 2–4 months: due diligence and SPA, the foreign-investment information report and company-law filings, and any sector licence. Add merger control where thresholds are met — the simplified track targets about 20 days for review plus filing time; the standard track can run longer. Add security review where scope and control are present — the 15 + 30 + 60 working-day path (plus extensions) can extend well beyond a year for sensitive cases. The three workstreams should run in parallel, but closing is gated by the slowest mandatory clearance.

Do not sequence the clearances serially. Begin merger-control and security-review analyses at term-sheet stage, because the documents and substantive analysis overlap with diligence; locking the structure before the reviews are scoped risks a late redesign. Build the long-stop date around the special-review maximum, not the preliminary-review minimum.

What to do next

  • Screen the target sector against the 2024 negative list; if restricted, confirm the equity/control condition can be met before signing.
  • Run a merger-control threshold test early (worldwide >RMB 12bn & two parties >RMB 800m China; or China aggregate >RMB 4bn & two parties >RMB 800m China).
  • Test security-review scope and “actual control” (50%+ equity, material voting influence, or material influence on decisions/personnel/finance/tech).
  • For listed targets, apply the 2024 strategic-investment rules and route through information reporting, not commerce approval.
  • Run merger control, security review and sector licensing in parallel; do not close until every mandatory clearance is in hand.
  • Set the long-stop around the special-review maximum, and begin both reviews at term-sheet stage.

Common misreads

Three mistakes recur. First, sequencing the clearances serially (merger control, then security review, then licence) when they should run in parallel — serial handling is the usual cause of a missed long-stop. Second, assuming that because a deal is below the merger-control thresholds no ex-ante review applies at all; security review can still be triggered by a covered sector and control, independent of size. Third, underestimating “actual control” for security review — a minority stake with veto rights can count — which leads teams to skip the screen and discover the gap late. Scoping both reviews at term-sheet stage is the single best defence.


2026年外资并购中国:审查地图与时间线

2020年后的交易框架

外国投资者收购中国公司现今置于《外商投资法》框架下,而非旧有的审批式并购规则。行为变化是决定性的:交易本身不再是商务部门审批事件。投资者依据公司法设立或转让,清除任何负面清单条件,报送外商投资信息,并在触发时分别通过市场监管总局(SAMR)的经营者集中(反垄断)审查与发改委牵头机制的国家安全审查。厘清究竟哪些关口适用并并行推进,是顺利交割的核心。

关口一——负面清单与信息报告

2024年全国外资负面清单含29条,于2024年11月1日施行。若目标行业在清单上,收购须满足其条件(股权上限、中方控股要求等);若不在清单上,则与境内并购平等对待。跨境换股允许但有条件——一般作为对价的外国股权应为境外上市公司股权,不过2024年战投规则对特定定向发行与要约收购结构有所放宽。交易后,外国投资者报送投资信息而非申请审批。

关口二——经营者集中(反垄断)申报

外国收购方须在实施达到门槛的集中前通知SAMR。依修订后的国务院规定(第773号令,2024年1月26日施行),上一会计年度所有当事人全球合计营业额超120亿元且至少两方中国境内各超8亿元,或当事人中国境内合计营业额超40亿元且至少两方中国境内各超8亿元,须申报。银行、保险、证券、期货按行业特别规则计算。

2024年修订将原有标准(100亿/20亿/4亿)提高至120亿/40亿/8亿元,SAMR估计可使申报量减少约30%、降低交易成本。交易不得在未获核准前实施;”抢跑”受罚。SAMR对简易案件设”双20天”目标(受理与审查各20天),并将试点委托地方审查转为正式委托(2025年8月试点转正式,2026年3月公告完善)。

成效实在:2025年SAMR依法审结经营者集中706件,同比增长9.8%,83%在30天初步审查阶段结案。在汽车、光伏、锂电池等重点领域,该局”快审不降质”以支持重组。

关口三——国家安全审查

当收购位于受涵盖敏感领域且外国投资者取得实际控制权时,须在实施前通过安全审查。《外商投资安全审查办法》(发改委、商务部,2020年12月19日发布,2021年1月18日施行)界定范围:国防及周围地区;以及重要农产品、能源资源、重大装备制造、重要基础设施、重要运输服务、重要文化、重要信息技术和互联网产品与服务、重要金融服务、关键技术等重要领域——且投资者取得实际控制权。

“实际控制”标准宽于经营者集中:包括持股50%以上;持股不足50%但表决权对董事会/股东会决议产生重大影响;或其他对经营决策、人事、财务、技术产生重大影响的情形。程序为初步(15个工作日决定是否审查)→一般审查(30个工作日)→特别审查(60个工作日,可延长);决定具终局性,可禁止、附条件批准或准予。因其可推翻已通过的经营者集中,安全审查是收购方须首先筛查的关口——且如2026年Meta–Manus禁止案所示,它正被积极执行(详见本系列专文)。

上市公司战略投资(2024更新)

若目标为上市公司,外国投资者还须遵守修订后的《外国投资者对上市公司战略投资管理办法》(六部门,第3号令,2024;2024年11月1日公布,2024年12月2日施行)。修订大幅降低门槛:允许外国自然人;资产门槛放宽(非控股者实有5000万美元或管理3亿美元;控股者1亿美元或管理5亿美元);跨境换股对定向发行与要约收购放宽;战略投资方式新增要约收购;协议转让/要约收购持股比由10%降至5%(定向发行取消比例要求);锁定期由3年降至12个月(其他规则有更长要求从其规定)。重要的是,战略投资不再需商务审批——经信息报告与证券市场规则办理,安全审查与经营者集中接口保留。

现实时间线

一项简单、无限制、未达门槛的收购约2–4个月可完成:尽调与SPA、外商投资信息报告与公司法律文件、以及行业许可。若达门槛则叠加经营者集中——简易案件审查约20天加申报时间;标准案件更久。若涉范围且取得控制权则叠加安全审查——15+30+60工作日路径(含延期)对敏感案件可远超一年。三项工作流应并行,但交割受最慢的强制核准制约。

切勿串行处理核准。应在条款书阶段即启动经营者集中与安全审查分析,因其文件与实质分析与尽调重叠;在审查范围确定前锁定结构,可能导致后期重构。长停日应围绕特别审查上限设定,而非初步审查下限。

下一步

  • 将目标行业对照2024年负面清单筛查;若受限,签约前确认股权/控制条件可满足。
  • 尽早做经营者集中门槛测试(全球超120亿且两方中国各超8亿;或中国合计超40亿且两方中国各超8亿)。
  • 测试安全审查范围与”实际控制”(50%以上股权、重大表决影响、或对决策/人事/财务/技术重大影响)。
  • 对上市公司目标,适用2024年战投规则,经信息报告而非商务审批路径。
  • 经营者集中、安全审查与行业许可并行;未获所有强制核准前不得交割。
  • 长停日围绕特别审查上限设定,并在条款书阶段即启动两项审查。

常见误读

三类错误反复出现。其一,将核准串行处理(先经营者集中、再安全审查、再许可),而它们本应并行——串行是错过长停日的常见原因。其二,以为交易未达经营者集中门槛便无需任何事前审查;安全审查可因受涵盖领域与控制独立触发,与规模无关。其三,低估安全审查的”实际控制”——具否决权的少数股权亦可能计入——导致团队跳过筛查、后期才发现缺口。在条款书阶段即并行界定两项审查,是最佳防御。

Sources

Foreign M&A in China: process & approvals

  • Since 2020, domestic-enterprise M&A is no longer a commerce-department approval event — it runs through the negative list, information reporting, plus merger control and security review where triggered.
    2020 年后,并购境内企业不再是商务部门审批事件——经负面清单、信息报告办理,并在触发时通过经营者集中与安全审查。
  • Merger-control thresholds (Order No. 773, effective 26 January 2024): worldwide >RMB 12bn and two parties >RMB 800m China, OR China aggregate >RMB 4bn and two parties >RMB 800m China; below-threshold deals can still need security review where scope and control exist.
    经营者集中门槛(第 773 号令,2024 年 1 月 26 日施行):全球 >120 亿且两方中国 >8 亿,或中国合计 >40 亿且两方中国 >8 亿;未达门槛的交易在涉范围且取得控制权时仍可能需安全审查。
  • SAMR’s simplified track targets a “double 20-day” review; gun-jumping (closing before clearance) draws penalties.
    市场监管总局简易案件推行”双 20 天”审查目标;”抢跑”(获批前实施)受罚。
  • Security review is required where the target is in a covered sensitive sector and the foreign investor acquires actual control; the control test is broader than merger control’s.
    当目标位于受涵盖敏感领域且外国投资者取得实际控制权时须通过安全审查;控制标准宽于经营者集中标准。
  • The 2024 strategic-investment rules (Order No. 3, effective 2 December 2024) ease listed-company investment: foreign natural persons allowed, lower asset thresholds (USD 50m owned / USD 3bn managed for non-controlling), tender offers added, lock-up cut to 12 months, and no commerce approval needed.
    2024 年战投规则(第 3 号令,2024 年 12 月 2 日施行)放宽上市公司投资:允许外国自然人、降低资产门槛(非控股者实有 5,000 万美元或管理 3 亿美元)、新增要约收购、锁定期降至 12 个月,且无需商务审批。
  • A straightforward below-threshold acquisition can close in roughly 2–4 months; security review’s 15+30+60 working-day path (extendable) can exceed a year for sensitive cases.
    一项简单未达门槛的收购约 2–4 个月可完成;安全审查 15+30+60 工作日路径(可延长)对敏感案件可超一年。
  • Run merger control, security review and sector licensing in parallel; do not close until every mandatory clearance is in hand, and begin the two reviews at term-sheet stage.
    将经营者集中、安全审查与行业许可并行推进;未获所有强制 clearance 前不得交割,并在条款书阶段启动两项审查。

Foreign M&A in China: process & approvals | 外资并购中国企业的流程与审批

Overview

Acquiring a domestic Chinese company as a foreign investor runs through the same foreign-investment framework as greenfield entry, plus two deal-specific gates: merger control (antitrust) clearance with SAMR and national security review where a covered sensitive sector and control are involved. The foundational rule is the Provisions on Foreign Investors’ Mergers of and Acquisitions of Domestic Enterprises (MOFCOM Order No. 6, 2009), now operating inside the Foreign Investment Law’s negative-list and information-reporting regime. This article maps the process, the filing thresholds, the security review, and a realistic timeline.

A key behavioural change since 2020: M&A of a domestic enterprise is no longer a commerce-department approval event by itself. The investor incorporates/transfers under company law, clears any negative-list condition, reports foreign-investment information, and separately clears merger control and security review where triggered. Understanding which gates actually apply — and running them in parallel — is the core of a smooth closing.

The M&A rule and negative-list applicability

The 2009 M&A provisions govern how a foreign investor acquires equity or assets of a domestic enterprise, or obtains control through other means. They sit beneath the Foreign Investment Law: if the target’s sector is on the negative list, the acquisition must satisfy the list’s conditions (equity caps, Chinese-control, etc.); if off the list, the deal is treated on equal terms with domestic M&A.

Cross-border share swaps are permitted but conditioned: as a general rule the foreign equity used as consideration should be in a listed overseas company, though the 2024 strategic-investment rules relaxed this for certain directed-issue and tender-offer structures (allowing unlisted overseas company equity). Where the target is a listed company, the foreign investor must also comply with the Measures for the Administration of Foreign Investors’ Strategic Investment in Listed Companies, and the deal must respect the negative list — for example, a foreign investor may not acquire control of a sector that the list reserves to Chinese control.

Merger control (antitrust) filing

A foreign acquirer must notify SAMR before implementing a concentration that meets the thresholds. Under the revised State Council regulation (Order No. 773, effective 26 January 2024), a concentration must be notified where, in the prior fiscal year, the worldwide aggregate turnover of all parties exceeds RMB 12 billion and at least two parties each had China turnover above RMB 800 million; OR the parties’ aggregate China turnover exceeds RMB 4 billion and at least two parties each had China turnover above RMB 800 million. Banking, insurance, securities and futures are calculated with sector-specific rules.

The 2024 thresholds raised the prior levels (RMB 10bn / RMB 2bn / RMB 400m) to RMB 12bn / RMB 4bn / RMB 800m, cutting the number of notifiable deals by an estimated 30%. A deal must not close before clearance; “gun-jumping” draws penalties. SAMR runs a simplified track with a “double 20-day” target for straightforward cases, and has piloted delegated review with selected provincial market-regulation bureaus to bring examination closer to the market.

National security review

Where the acquisition is in a covered sensitive sector (defence, important agriculture/energy/equipment/infrastructure/transport/culture/IT/finance/key tech) and the foreign investor acquires actual control, security review is required before implementation. The control test is broader than the merger-control test, so review can be triggered even when no antitrust filing is needed. The procedure runs preliminary (15 working days) → general (30) → special (60, extendable) review; the decision is final and can prohibit or condition the deal. Because it can override a cleared merger filing, security review is the gate an acquirer must screen first.

Strategic investment in listed companies (2024 update)

The revised Measures for Foreign Investors’ Strategic Investment in Listed Companies (six agencies, Order No. 3, 2024; effective 2 December 2024) lower the bar materially: foreign natural persons are allowed; asset thresholds are eased (non-controlling investors need only USD 500m owned or USD 3bn managed); tender offers are added as a method; cross-border share swaps are eased for directed issues and tender offers; and the lock-up is cut from three years to twelve months (longer if other rules require). Importly, post-Foreign-Investment-Law, strategic investment no longer requires commerce-department approval — it is handled through information reporting and the securities-market rules, with security-review and merger-control interfaces preserved.

Typical timeline

A straightforward, unrestricted, below-threshold acquisition can complete in roughly 2–4 months: due diligence and SPA (variable), the foreign-investment information report and company-law filings (weeks), and any sector licence. Add merger control where thresholds are met (the simplified track targets ~20 days for review plus filing time; the standard track can run longer). Add security review where scope and control are present — the 15 + 30 + 60 working-day path (plus extensions) can extend well beyond a year for sensitive cases. The three workstreams should run in parallel, but closing is gated by the slowest mandatory clearance.

A practical tip: do not sequence the clearances serially. Begin merger-control and security-review analyses at term-sheet stage, because the documents and the substantive analysis overlap with diligence; locking the structure before the reviews are scoped risks a redesign late in the process. Build the long-stop date around the special-review maximum, not the preliminary-review minimum.

What to do next

Common misreads

Three mistakes recur in cross-border deals. The first is sequencing the clearances serially — merger control, then security review, then licence — when they should run in parallel; serial handling is the usual cause of a missed long-stop. The second is assuming that because a deal is below the merger-control turnover thresholds, no ex-ante review applies at all; security review can still be triggered by a covered sector and control, independent of size. The third is underestimating the breadth of “actual control” for security review — a minority stake with veto rights can count — which leads teams to skip the screen and discover the gap late. Scoping both reviews at term-sheet stage is the single best defence.

  • Screen the target sector against the 2024 negative list; if restricted, confirm the equity/control condition can be met before signing.
  • Run a merger-control threshold test early (worldwide >RMB 12bn & two parties >RMB 800m China; or China aggregate >RMB 4bn & two parties >RMB 800m China).
  • Test security-review scope and “actual control” (50%+ equity, material voting influence, or material influence on decisions/personnel/finance/tech).
  • For listed-company targets, apply the 2024 strategic-investment rules and route through information reporting, not commerce approval.
  • Run merger control, security review and sector licensing in parallel; do not close until every mandatory clearance is in hand.
  • Set the long-stop around the special-review maximum, and begin the two reviews at term-sheet stage rather than after signing.

Sources

Related reading

  • see also: National security review of foreign investment
  • see also: FIE admission rules: approval vs. filing
  • see also: One-stop foreign investment service windows

外资并购中国企业的流程与审批

概述

外国投资者收购中国境内企业,遵循与绿地投资相同的外资框架,外加两道交易专属关卡:市场监管总局的经营者集中(反垄断)审查,以及涉及受涵盖敏感领域并取得控制权时的外商投资安全审查。基础规则是《关于外国投资者并购境内企业的规定》(商务部 2009 年第 6 号令),现运行于《外商投资法》的负面清单与信息报告制度之下。本文梳理流程、申报门槛、安全审查与合理时间表。

2020 年后的关键行为变化:并购境内企业本身不再是商务部门审批事件。投资者依公司法完成转让/设立,满足负面清单条件,报送外商投资信息,并在触发时另行通过经营者集中与安全审查。弄清哪些关卡真正适用——并并行推进——是顺利交割的核心。

并购规则与负面清单适用

2009 年并购规定规范外国投资者取得境内企业股权或资产,或通过其他方式取得控制权。其置于《外商投资法》之下:若目标行业在负面清单上,收购须满足清单条件(股比上限、中方控股等);若不在清单上,则按内资并购同等对待。

跨境换股被允许但有条件:一般规则下作为支付对价的外国股权应为境外上市公司股权,但 2024 年战投规则对特定定向发行与要约收购结构有所放宽(允许境外非上市公司股权)。目标为上市公司的,还须遵守《外国投资者对上市公司战略投资管理办法》,且交易须尊重负面清单——例如,外国投资者不得取得清单保留由中方控股行业的控制权。

经营者集中(反垄断)申报

外国收购方须在实施达到门槛的集中前,向市场监管总局申报。依修订后的国务院规定(第 773 号令,2024 年 1 月 26 日施行),上一会计年度参与集中各方全球合计营业额超 120 亿元且至少两方中国境内营业额均超 8 亿元;或各方中国境内合计营业额超 40 亿元且至少两方中国境内营业额均超 8 亿元,即须申报。银行、保险、证券、期货按行业特别办法计算。

2024 年门槛将原标准(100 亿/20 亿/4 亿)提高至 120 亿/40 亿/8 亿,预计减少约 30% 应申报交易。交易须在获批前不得实施;”抢跑”受罚。市场监管总局简易案件推行受理与审查”双 20 天”目标,并试点委托部分省级市场监管局开展审查,使审查更贴近市场。

外商投资安全审查

当收购位于受涵盖敏感领域(军工、重要农业/能源/装备/基础设施/运输/文化/信息技术/金融/关键技术)且外国投资者取得实际控制权时,须在实施前通过安全审查。控制标准宽于经营者集中标准,故即便无需反垄断申报,仍可能触发审查。程序为初步审查(15 个工作日)→ 一般审查(30)→ 特别审查(60,可延长);决定为最终决定,可禁止或附条件。因其可凌驾于已通过的经营者集中申报,安全审查是收购方须最先筛查的关卡。

上市公司战略投资(2024 更新)

修订后的《外国投资者对上市公司战略投资管理办法》(六部门,2024 年第 3 号令,2024 年 12 月 2 日施行)大幅降低门槛:允许外国自然人;资产要求放宽(非控股股东仅需实有资产 5,000 万美元或管理资产 3 亿美元);新增要约收购方式;定向发行与要约收购的跨境换股放宽;锁定期由三年降至十二个月(其他规则有更长要求的从其规定)。重要的是,在外商投资法后,战略投资不再需商务部门审批——经信息报告与证券市场规则办理,安全审查与经营者集中接口保留。

典型时间表

一项简单、不受限、未达门槛的收购约 2–4 个月可完成:尽调与股权协议(可变)、外商投资信息报告与公司法项下登记(数周)、及相关行业许可。达到门槛的加经营者集中(简易案件审查目标约 20 天加申报时间;普通案件可能更久)。涉范围且取得控制权的加安全审查——15 + 30 + 60 工作日路径(可延长)对敏感案件可远超一年。三道工作流应并行,但交割受最慢的强制 clearance 约束。

实务提示:勿将各项 clearance 串行。在条款书阶段即启动经营者集中与安全审查分析,因其文件与实质分析与尽调重叠;在审查范围确定前锁定结构,可能导致流程后期重构。长止期应围绕特别审查上限而非初步审查下限设定。

下一步建议

常见误读

跨境交易中有三类反复出现的错误。其一,将各项 clearance 串行——先经营者集中,再安全审查,再许可——而它们应并行;串行处理是错过长止期的常见原因。其二,以为交易未达经营者集中营业额门槛即完全无需事前审查;受涵盖领域加控制权仍可触发安全审查,与规模无关。其三,低估安全审查”实际控制”的广度——具否决权的少数股权亦可计入——导致团队跳过筛查、后期才发现缺口。在条款书阶段即对两项审查做范围筛查,是最佳防御。

  • 将目标行业对照 2024 年版负面清单;若受限,签约前确认股比/控股条件可满足。
  • 尽早做经营者集中门槛测试(全球 >120 亿且两方中国 >8 亿;或中国合计 >40 亿且两方中国 >8 亿)。
  • 测试安全审查范围与”实际控制”(50% 以上股权、重大表决影响,或对决策/人事/财务/技术的重大影响)。
  • 目标为上市公司的,适用 2024 年战投规则,经信息报告而非商务审批办理。
  • 将经营者集中、安全审查与行业许可并行推进;未获所有强制 clearance 前不得交割。
  • 长止期围绕特别审查上限设定,并在条款书阶段而非签约后启动两项审查。

来源

相关阅读

  • 参见:外商投资安全审查
  • 参见:外资企业准入:审批与备案
  • 参见:外商投资一站式服务窗口